Literature DB >> 19222190

Quantitative detection of HIV-1 particles using HIV-1 neutralizing antibody-conjugated beads.

Byoung Chan Kim1, Moon Kyeong Ju, Alexey Dan-Chin-Yu, Peter Sommer.   

Abstract

The human immunodeficiency virus (HIV) pandemic mainly affects developing countries, where the Joint United Nations Programme on HIV/AIDS (UNAIDS) estimates suggest that less than 1 in 10 people are aware of their HIV sero-status. In order to enhance epidemiological surveys, prevention programs, and therapeutic interventions, development of specific, rapid, and convenient diagnostic detection systems is still warranted. Here we report the direct detection of HIV particles using broadly HIV-1 neutralizing gp120 monoclonal antibody (gp120MAbs)-conjugated magnetic beads (MBs) and fluorescent nanosized polymeric beads (FNBs). The HIV-1 envelope glycoprotein gp120 is anchored to the viral surface through gp41 and mediates entry into target cells by interaction with the main cellular receptor (CD4) and coreceptors (e.g., CCR5 and CXCR4). FNBs conjugated to gp120MAbs (gp120MAbs-FNBs) were used to generate fluorescent signals, whereas MBs conjugated to gp120MAbs (gp120MAbs-MBs) were employed to isolate HIV-1 particles. In presence of HIV-1 particles, addition of gp120MAbs-FNBs and gp120MAbs-MBs leads to the formation of a MBs/HIV-1 particles/FNB complex, which can be easily isolated and concentrated by common magnet separation. We demonstrate the ability of detecting HIV-1 particles specifically and directly using MBs and FNBs with low sample volume (less than 100 microL) and rapidity (less than 1.5 h) without any pretreatment of test samples. The specific binding of FNBs with HIV-1 particles on the surface of MBs was confirmed by fluorescence microscopy and fluorescence-activated cell sorting (FACS). Imaging and FACS analysis revealed the specific and quantitative detection of HIV-1 particles. These results provide proof-of-principle that broadly HIV-1 neutralizing gp120 antibodies coupled to nanobeads can be employed for the direct detection of HIV-1 particles with potential implication for the development of specific, rapid, and convenient diagnostic systems.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222190     DOI: 10.1021/ac802267u

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

1.  Nanoparticle-based flow virometry for the analysis of individual virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Leonid Margolis; Jean-Charles Grivel
Journal:  J Clin Invest       Date:  2013-08-08       Impact factor: 14.808

2.  Antitumor activity and immunogenicity of recombinant vaccinia virus expressing HPV 16 E7 protein SigE7LAMP is enhanced by high-level coexpression of IGFBP-3.

Authors:  J Musil; L Kutinova; K Zurkova; P Hainz; K Babiarova; J Krystofova; S Nemeckova
Journal:  Cancer Gene Ther       Date:  2014-02-21       Impact factor: 5.987

3.  Efficient on-chip isolation of HIV subtypes.

Authors:  ShuQi Wang; Matin Esfahani; Umut A Gurkan; Fatih Inci; Daniel R Kuritzkes; Utkan Demirci
Journal:  Lab Chip       Date:  2012-03-06       Impact factor: 6.799

4.  Development of a Specific Anti-capsid Antibody- and Magnetic Bead-Based Immunoassay to Detect Human Norovirus Particles in Stool Samples and Spiked Mussels via Flow Cytometry.

Authors:  Ravo M Razafimahefa; Louisa F Ludwig-Begall; Mamadou Amadou Diallo; Benjamin G Dewals; Alain Vanderplasschen; Olivier Nivelles; Caroline Deketelaere; Axel Mauroy; Etienne Thiry
Journal:  Food Environ Virol       Date:  2021-08-07       Impact factor: 2.778

5.  Characterization of HIV-1 subtypes and drug resistance mutations in Henan Province, China (2017-2019).

Authors:  Zhaojie Yang; Shuguang Wei; Jinjin Liu; Junyan Piao; Lixia Xu; Yan Sun; Xin Deng; Xuan Yang; Chunli Liu; Shuhuan Ma; Qingxia Zhao; Yuqi Huo
Journal:  Arch Virol       Date:  2020-04-11       Impact factor: 2.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.